A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
India’s pharmaceutical sector stands at a pivotal inflection point
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
The State’s PPP model has already mobilised Rs. 150 crore in core infrastructure, while Thermo Fisher has invested Rs. 90 crore in the Bioprocess Design Centre and its co-located Customer Experience Centre
Desai is currently serving the company as Group Finance Controller
The partnership will enable rapid and reliable product delivery
Subscribe To Our Newsletter & Stay Updated
